Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-25 12:19 pm Purchase | 13G | China SXT Pharmaceuticals Inc. SXTC | Streeterville Capital LLC | 405,837 9.990% | 405,837 (New Position) | View |
| 2024-08-15 09:45 am Sale | 13G | China SXT Pharmaceuticals Inc. SXTC | Forsakringsaktiebolaget Avanza Pension | 45 1.290% | -30,634 (-99.85%) | View |
| 2024-05-31 10:36 am Purchase | 13G | China SXT Pharmaceuticals Inc. SXTC | Forsakringsaktiebolaget Avanza Pension | 30,679 5.420% | 17,242 (+128.32%) | View |
| 2024-02-09 10:14 am Sale | 13G | China SXT Pharmaceuticals Inc. SXTC | Forsakringsaktiebolaget Avanza Pension | 13,437 2.380% | -15,243 (-53.15%) | View |
| 2024-02-09 06:36 am Purchase | 13G | China SXT Pharmaceuticals Inc. SXTC | Forsakringsaktiebolaget Avanza Pension | 28,680 5.070% | 28,680 (New Position) | View |
| 2023-03-29 2:19 pm Purchase | 13G | China SXT Pharmaceuticals Inc. SXTC | Streeterville Capital LLC | 1,043,580 9.990% | 1,043,580 (New Position) | View |
| 2023-03-29 1:48 pm Sale | 13G | China SXT Pharmaceuticals Inc. SXTC | Streeterville Capital LLC | 0 0.000% | -202,936 (Position Closed) | View |
| 2023-02-13 4:28 pm Unchanged | 13G | China SXT Pharmaceuticals Inc. SXTC | Lind Global Fund II LP | 0 0.000% | 0 (Unchanged) | View |
| 2023-01-30 4:05 pm Purchase | 13D | China SXT Pharmaceuticals Inc. SXTC | Zhou Albert Feng | 1,732,048 21.498% | 1,732,048 (New Position) | View |
| 2022-08-25 3:57 pm Purchase | 13G | China SXT Pharmaceuticals Inc. SXTC | Streeterville Capital LLC | 202,936 9.990% | 202,936 (New Position) | View |
| 2022-01-21 5:01 pm Purchase | 13G | China SXT Pharmaceuticals Inc. SXTC | Lind Global Fund II LP | 2,575,000 9.900% | 2,575,000 (New Position) | View |
| 2021-02-16 1:47 pm Sale | 13G | China SXT Pharmaceuticals Inc. SXTC | Ayrton Capital LLC | 298,330 0.400% | -2,369,669 (-88.82%) | View |
| 2021-02-10 5:45 pm Sale | 13G | China SXT Pharmaceuticals Inc. SXTC | Hudson Bay Capital Management LP | 298,329 0.480% | -2,443,810 (-89.12%) | View |
| 2020-02-14 2:06 pm Purchase | 13G | China SXT Pharmaceuticals Inc. SXTC | Ayrton Capital LLC | 2,667,999 9.990% | 667,999 (+33.40%) | View |
| 2020-02-07 3:35 pm Purchase | 13G | China SXT Pharmaceuticals Inc. SXTC | Hudson Bay Capital Management LP | 2,742,139 9.990% | 2,742,139 (New Position) | View |